ER-100 First Human Dosed: The Rejuvenation Test Has Left the Lab
The first human dosing of ER-100 does not prove age reversal. It starts the evidence clock for one of longevity's boldest ideas.
Editorial atlas for the intelligence transition
The future is arriving badly explained.
Vastkind tracks the evidence, bottlenecks, and power shifts behind AI, compute, biology, energy, and autonomy.
Tracking
AI
Compute
Biology
Energy
Power
David Sinclair's XPRIZE Rejuvenation Plan Has a Proof Problem
Why it matters
Read the analysis →
The real story is not another anti-aging pill claim. It is whether whole-body rejuvenation can survive XPRIZE's measurement machine.
Current briefing
Read the pressure before it becomes consensus.
One lead read, three signal checks, and the pressure points before they harden into consensus.
The Vastkind Briefing
A sharper read on the systems beneath the headline.
Built for readers who need the signal, the evidence boundary, and the leverage map before a story becomes consensus.
Get the briefingWhat changed
The concrete shift: model capability, capital flow, policy move, trial result, infrastructure pressure.
Why it matters
The second-order effect: who gains leverage, which assumptions break, and what becomes newly possible.
What to watch
The evidence and bottlenecks that decide whether the story compounds, stalls, or changes direction.
The Vastkind field guide
Seven frontiers where the future is breaking open.
A working map of the systems Vastkind tracks: AI, robotics, and longevity up front; compute, energy, biotech, and quantum as the deeper pressure routes.
AI
Models, agents, governance, deployment pressure.
Frontier AI Governance Is Becoming an Evaluation-Audit Problem
Compute
Chips, memory, data centers, energy, capital.
Orbital Data Centers: When AI Compute Tries to Leave Earth
Longevity
Evidence, biomarkers, claims, healthspan science.
ER-100 First Human Dosed: The Rejuvenation Test Has Left the Lab
Robotics
Embodiment, safety, labor, autonomy.
China’s Robotics Strategy Is About Industrial Power, Not Humanoid Hype
Biotech
Programmable biology, labs, data, medicine.
Hepcludex FDA Approval: What Bulevirtide Changes for Chronic Hepatitis D
Quantum
Hardware, cryptography, materials, timing risk.
Post-Quantum Cryptography Is Becoming an Inventory Problem
Energy
Power, grids, industrial constraints, compute demand.
Carbon Removal Is Becoming Net Zero's Hidden Credibility Test
The transition Vastkind tracks
This is not a chatbot cycle. It is the race to automate knowledge.
The important story is the chain reaction: stronger models, agentic workflows, automated research, compute and energy bottlenecks, institutional compression, and the pressure toward AGI and ASI. Vastkind follows that chain before it becomes obvious.
Reasoning becomes infrastructure
Models stop feeling like apps and start becoming a layer inside science, work, policy, security, markets, and media.
Agents turn intent into operations
Software shifts from passive tools to systems that plan, call tools, coordinate steps, and act across organizations.
The autonomous scientist appears
AI begins to generate hypotheses, design experiments, read results, write code, and compress discovery cycles.
Compute becomes strategic territory
Chips, memory, data centers, energy, grids, capital, and talent become the hidden map of who can move fastest.
Institutions get compressed
Governance, labor markets, education, safety standards, health claims, and public trust react slower than capability.